United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 295.52 USD -1.55% Market Closed
Market Cap: 13.3B USD

Relative Value

The Relative Value of one UTHR stock under the Base Case scenario is 320.59 USD. Compared to the current market price of 295.52 USD, United Therapeutics Corp is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

UTHR Relative Value
Base Case
320.59 USD
Undervaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
61
Median 3Y
5.3
Median 5Y
5.1
Industry
7.5
Forward
4
vs History
84
vs Industry
10
Median 3Y
13.2
Median 5Y
13.5
Industry
23.6
Forward
10.3
vs History
82
vs Industry
13
Median 3Y
11.9
Median 5Y
11.9
Industry
20.2
vs History
28
vs Industry
9
Median 3Y
18.7
Median 5Y
17
Industry
22.9
vs History
68
vs Industry
39
Median 3Y
2.1
Median 5Y
2.2
Industry
2.8
vs History
82
vs Industry
57
Median 3Y
4.2
Median 5Y
4.3
Industry
7.7
Forward
3
vs History
82
vs Industry
59
Median 3Y
4.7
Median 5Y
4.7
Industry
9.6
vs History
82
vs Industry
12
Median 3Y
8.1
Median 5Y
8.3
Industry
4.9
Forward
5.9
vs History
82
vs Industry
11
Median 3Y
8.5
Median 5Y
8.8
Industry
4.9
Forward
6.7
vs History
85
vs Industry
14
Median 3Y
9.8
Median 5Y
9.8
Industry
5.4
vs History
82
vs Industry
10
Median 3Y
12.2
Median 5Y
12.2
Industry
4
vs History
61
vs Industry
40
Median 3Y
2.7
Median 5Y
2.6
Industry
5.1

Multiples Across Competitors

UTHR Competitors Multiples
United Therapeutics Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
United Therapeutics Corp
NASDAQ:UTHR
13.3B USD 4.4 11 6.8 7.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 932 910.7 -161 278.1 -195 843 -193 608.2
US
Abbvie Inc
NYSE:ABBV
339.9B USD 5.9 81.8 15.5 23
US
Amgen Inc
NASDAQ:AMGN
158.8B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.5B USD 4.8 22.9 10 13.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.5B USD 10.9 -121.8 25.9 27.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.1 -529.8 -576.9 -561.5
AU
CSL Ltd
ASX:CSL
117.4B AUD 5.1 28.1 17.3 21.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.4B USD 4.4 13.7 12.2 13.7
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.3 -66.1 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41B USD 17.5 -152.2 -682.1 -341.8
P/E Multiple
Earnings Growth PEG
US
United Therapeutics Corp
NASDAQ:UTHR
Average P/E: 30.7
11
4%
2.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 278.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.9
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -121.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.8 N/A N/A
AU
CSL Ltd
ASX:CSL
28.1
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
7%
2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -152.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
United Therapeutics Corp
NASDAQ:UTHR
Average EV/EBITDA: 14.6
6.8
2%
3.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 843 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.9 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -682.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
United Therapeutics Corp
NASDAQ:UTHR
Average EV/EBIT: 18.6
7.1
6%
1.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 608.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.2
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.7
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -341.8 N/A N/A